Analyst warns Bitcoin may mirror its painful collapse from 2022.
Merck, a leading global science and technology company, today announced that the European Commission (EC) approved an update ...
BTC reclaimed the 20/50 EMAs and is pressing toward the 100 EMA, with a clear support pocket at $60,400–$60,700. Key Risk: A ...
Learn why Shiller CAPE and Buffett Indicator miss sell signals. Use an overvaluation matrix + 10-month SMA/TRF trend rules ...
Bitcoin onchain analysis eyes one of its "cleanest cycle clocks" for cues as to when the bear-market bottom will hit, with ...
Bitcoin backtracked holiday gains as markets reacted to news that Strategy had sold nearly 3,600 BTC through July 5.
After plummeting from 2022 to 2024, the amount of waste generated by New Zealanders held steady in 2025, though significantly ...
Europe's drug regulator on Friday recommended revoking the marketing authorization for Amgen's rare autoimmune disease medicine, citing concerns over the ...
The recommendation in Europe follows a similar move by the FDA earlier this year.
Ten years after the first etanercept copy reached European patients, the EMA, real-world registries and rheumatologists have ...
Recently published Alport Syndrome Market Insights report includes a comprehensive understanding of current treatment ...
We’ve built global highways for approved medicines and left clinical trial access on something closer to dirt roads.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results